Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$1.5 - $2.71 $5.01 Million - $9.05 Million
-3,338,718 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$1.04 - $1.73 $687,733 - $1.14 Million
-661,282 Reduced 16.53%
3,338,718 $5.41 Million
Q4 2019

Feb 13, 2020

BUY
$1.02 - $1.97 $2.55 Million - $4.93 Million
2,500,000 Added 166.67%
4,000,000 $7.56 Million
Q4 2018

Feb 14, 2019

BUY
$6.3 - $15.4 $9.45 Million - $23.1 Million
1,500,000 New
1,500,000 $11.1 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Mfn Partners Management, LP Portfolio

Follow Mfn Partners Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mfn Partners Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mfn Partners Management, LP with notifications on news.